Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-09

Clinical Trial Update: A Study to Assess the Drug-drug Interaction of BMS 663068 With Methadone and Also With Buprenorphine/Naloxone [Phase 1]

View source ↗

Summary

Phase 1 study completed evaluating potential drug-drug interactions between fostemsavir (BMS-663068) and methadone, and between fostemsavir and buprenorphine/na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methadone (methadone)
  • Rukobia (fostemsavir)
  • SUBOXONE (buprenorphine hydrochloride, naloxone hydrochloride)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED